» Articles » PMID: 9190929

Bcl-2 Prevents Apoptosis Induced by Perforin and Granzyme B, but Not That Mediated by Whole Cytotoxic Lymphocytes

Overview
Journal J Immunol
Date 1997 Jun 15
PMID 9190929
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Two pathways have been implicated in the induction of apoptosis by cytotoxic T cells: the granule exocytosis pathway and a pathway using CD95 (Fas/APO-1). To test whether apoptosis induced by either of these pathways could be blocked by Bcl-2, we exposed bcl-2-transfected cells to CTL derived from normal, perforin-deficient, or CD95 ligand mutant (gld) mice. Although the levels of Bcl-2 expression achieved were able to protect FDC-P1 and Yac-1 transfectants from a variety of apoptotic stimuli, the cells were not protected from cytolysis mediated by CTL from any of these sources, by NK cells, or granules isolated from CTL. However, Bcl-2 expression significantly inhibited apoptosis induced by purified granzyme B and perforin. These results suggest that while Bcl-2 is capable of inhibiting the apoptotic pathway utilized by perforin and granzyme B, other granule components can bypass this block. We conclude that CTL harbor potent killing mechanism(s) in addition to those provided by CD95 ligand or perforin and granzyme B that cannot be overcome by Bcl-2.

Citing Articles

Host immune responses against African swine fever virus: Insights and challenges for vaccine development.

Orosco F Open Vet J. 2024; 13(12):1517-1535.

PMID: 38292721 PMC: 10824091. DOI: 10.5455/OVJ.2023.v13.i12.2.


The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells.

Copertino Jr D, Holmberg C, Weiler J, Ward A, Howard J, Levinger C JCI Insight. 2023; 8(18).

PMID: 37581929 PMC: 10561764. DOI: 10.1172/jci.insight.169028.


The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model.

Chandrasekar A, Cummins N, Natesampillai S, Misra A, Alto A, Laird G J Virol. 2022; 96(24):e0173022.

PMID: 36448802 PMC: 9769373. DOI: 10.1128/jvi.01730-22.


Prime, shock and kill: BCL-2 inhibition for HIV cure.

Chandrasekar A, Badley A Front Immunol. 2022; 13:1033609.

PMID: 36341439 PMC: 9631312. DOI: 10.3389/fimmu.2022.1033609.


Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity.

Tuomela K, Ambrose A, Davis D Front Immunol. 2022; 13:867098.

PMID: 35401556 PMC: 8984481. DOI: 10.3389/fimmu.2022.867098.